Relafen 750, chemically known as naproxen sodium , represents a fascinating case study within the biochemical discipline of pain alleviation. Its mechanism of action involves the selective inhibition of cyclooxygenase-2 (COX-2), an enzyme critical for the synthesis of inflammatory mediators . Unlike non-selective NSAIDs, Relafen's comparatively pre

Relafen 750, chemically known as its salt form, offers a unique physiological pathway of action. From a drug angle , it functions primarily as a NSAID agent , inhibiting COX enzymes – specifically COX-1 and COX-2 – to alleviate pain and temperature . The ensuing decrease in inflammatory mediator production impacts a diverse array of physiologic